Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Aevi Genomic Medicine, Inc. (CERC)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.028.610.210.58.97.26.0
            Revenue growth   -100.0%180.3%-2.9%18.3%23.4%20.0%0.6%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.028.610.210.58.97.26.0
            Gross margin    100.0%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]8.79.513.513.010.710.57.24.9
Research and development  22.325.256.933.818.716.212.611.0
EBITDA   [+]-30.9-34.6-41.6-36.3-18.7-17.6-12.5-9.9
            EBITDA margin    -145.7%-356.6%-178.4%-198.9%-173.7%-165.0%
Depreciation and amortization  0.10.10.30.20.20.20.10.1
EBIT   [+]-31.0-34.7-41.9-36.6-18.9-17.8-12.6-10.0
            EBIT margin    -146.7%-359.0%-180.5%-200.9%-175.7%-166.6%
Interest income, net   [+]0.20.00.00.00.00.00.00.0
Other income (expense), net   [+]0.00.00.0-1.40.50.7-2.41.9
Pre-tax income  -30.8-34.7-41.9-38.0-18.4-17.1-15.1-8.1
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%      
Net income  -30.8-34.7-41.9-38.0-18.4-17.1-15.1-8.1
            Net margin    -146.8%-373.0%-175.7%-193.1%-209.7%-135.2%
   
Basic EPS   [+]($0.50)($0.83)($1.19)($1.42)($0.96)($0.97)($1.37)($0.96)
Diluted EPS   [+]($0.50)($0.83)($1.19)($1.42)($0.96)($0.97)($1.37)($0.96)
   
Shares outstanding (basic)   [+]61.441.735.226.819.217.611.08.4
Shares outstanding (diluted)   [+]61.441.735.226.819.317.711.08.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy